Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million

Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised $625 million in an upsized initial public offering, marking the sector’s biggest US listing since 2021.